YXC-002

N/A

Report date: 2025/09/10 16:17:39
NME

Base Information

Drug NameYXC-002
Drug Alias NameYXC-002
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionEpidermal growth factor receptor erbB1 inhibitors
TargetsEpidermal growth factor receptor erbB1
Therapy Area/IndicationsCentral Nervous System DiseasesCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai Yizhong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai Yizhong Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsCentral Nervous System DiseasesCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A